Oxford Drug Design
The company develops therapeutics by combining artificial intelligence and machine learning with expertise in tRNA synthetase enzyme targeting. Its proprietary platform is used to discover and develop novel treatments for cancer and other major diseases. The firm operates as a biotechnology entity focused on rapid drug discovery and pipeline development.
Visit websiteOxford, UK
Biotechnology
Artificial Intelligence
Healthcare
Drug Discovery
Funding summary
- Total raised
- €2.6M
- Funding rounds
- 1
Investors in Oxford Drug Design
Investors on record for Oxford Drug Design. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Oxford Drug Design?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors